• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • CRO Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Trending
Hamburger Menu Hamburger Menu
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • CRO Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us

Gemini Therapeutics

chutes and ladders chutes
Biotech

J&J's Mammen abruptly leaves top R&D job—Chutes & Ladders

J&J's Mammen abruptly leaves top R&D post. Biden taps Bertagnolli to be first woman director of the NCI. Lilly names new COO for oncology wing.
Max Bayer , Gabrielle Masson Aug 12, 2022 9:30am
acquisition merger MA chess game

Disc inks Gemini merger, secures cash from starry VC syndicate

Aug 10, 2022 7:30am
exit sign

Layoff 'wave' not letting up amid oversaturation of biotechs

Mar 28, 2022 10:05am
Exit sign

Gemini CEO exits, 80% of staff laid off as biotech soul searches

Feb 28, 2022 1:43pm
Eye

Gemini axes CSO and 20% of staff to focus on late-phase plans

Oct 5, 2021 8:30am
Light at the end of the tunnel

Lightstone raises $375M for third fund after 3 big exits in 2020

Sep 14, 2021 10:05am

Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Pharma
    • Fierce Biotech
    • Fierce Healthcare
  • Our Events
    • Life Sciences Events
©2025 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings